Cayuga Biotech

Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes. Founded in 2015, Cayuga Biotech is backed by investors that include IndieBio and SOSV and is headquartered in Bridgewater.
The Pulse of New York Tech
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.